Gilead Sciences Inc is > 10% Shareholder of ASSEMBLY BIOSCIENCES, INC.. Currently has a direct ownership of 1.27 Million shares of ASMB, which is worth approximately $17.4 Million. The most recent transaction as insider was on Jun 17, 2024, when has been sold 179,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.27M
n/a 3M change
n/a 12M change
Total Value Held $17.4 Million

GILEAD SCIENCES INC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 17 2024
BUY
Open market or private purchase
-
179,500 Added 12.39%
1,268,972 Common Stock

Also insider at

RCUS
Arcus Biosciences, Inc. Healthcare
ALVR
Allovir, Inc. Healthcare
XLO
Xilio Therapeutics, Inc. Healthcare
KYTX
Kyverna Therapeutics, Inc.
GSI

Gilead Sciences Inc

> 10% Shareholder
Foster City, CA

Track Institutional and Insider Activities on ASMB

Follow ASSEMBLY BIOSCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ASMB shares.

Notify only if

Insider Trading

Get notified when an Assembly Biosciences, Inc. insider buys or sells ASMB shares.

Notify only if

News

Receive news related to ASSEMBLY BIOSCIENCES, INC.

Track Activities on ASMB